Furthermore, studies have indicated that FGF-R1 is amplified in 20% of squamous non-small cell lung cancers (25) and mutations of FGF-R2 have been described in 12% of endometrial carcinomas (26). The gene discussed is FGFR1; the disease is non-small cell squamous lung carcinoma.